AKIPRESS.COM - Kazakh Prime Minister Askar Mamin launched the construction of a biopharmaceutical vaccine manufacturing plant at the Research Institute of Biological Safety of the Committee of Sciences of the Ministry of Education and Science in the village of Gvardeysky, Korday district, in Zhambyl region. 

The plant will produce immunobiological drugs according to the international standard of good manufacturing practice, including coronavirus vaccines. Currently, the candidate vaccine of the Kazakhstan Research Institute against COVID-19 is included in the WHO list and is successfully undergoing preclinical trials, his press office said. 

The company will also produce vaccines against pandemic influenza, tuberculosis, brucellosis, nodular dermatitis, plague of small ruminants, contagious ectima of sheep and goats, sheep pox, rabies and other infectious diseases.

It is planned to complete the construction in December 2020 and annually produce up to 60 million doses of biopharmaceuticals.